Welcome to our dedicated page for Home Bancshares SEC filings (Ticker: HOMB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Home BancShares, Inc. filings document the public-company reporting of a bank holding company and its Centennial Bank subsidiary. Form 8-K reports furnish quarterly earnings releases, Regulation FD disclosures, material-event updates, and completed acquisition activity, including merger documentation for bank-holding-company and subsidiary-bank transactions.
Proxy and shareholder-meeting filings cover board elections, advisory compensation votes, director appointments, executive compensation, equity award disclosure, and other governance matters. The company’s filings also address capital-structure items, voting results, operating and financial results, and disclosure controls relevant to a NYSE-listed banking organization.
Home BancShares, Inc. (HOMB) Form 4 – key take-aways
Centennial Bank CEO John Stephen Tipton filed a Form 4 covering a single open-market sale executed on 20 June 2025. The filing shows he disposed of 24,159 common shares (transaction code S) at $27.52 per share, a cash value of roughly $664.9 thousand. After the sale his direct ownership stands at 53,308 shares.
Equity still held
- Performance-based common shares: 10,000 (granted 19 Jul 2018; vest 33⅓% per year beginning 31 Mar 2024 after the performance goal was met on 31 Mar 2021).
- Restricted stock: 75,000 (granted 13 May 2024; vests 25% annually starting 13 May 2025).
- 401(k) plan: 26,049.191 shares, including 315.124 shares accumulated since the prior filing.
- Performance stock option: 12,000 options with a $23.32 exercise price, expiring 19 Jul 2028; first tranche became exercisable 31 Mar 2022.
Context & magnitude
The direct sale represents approximately 31% of Tipton’s pre-transaction directly-held common stock (77,467 shares). Despite the sale, he retains significant exposure through 53,308 directly-held shares plus 97,049 deferred/unvested equity instruments that tie his long-term incentives to share-price performance.
No other transactions in derivative securities were reported for the period, and the filing indicates no 10b5-1 plan was used.